Galderma Canada is a pharmaceutical company specializing in research and marketing of therapeutic, corrective and aesthetic solutions for dermatology patients. Our expertise spans a broad spectrum of skin and hair diseases. Our growing portfolio includes treatments for skin conditions such as acne, rosacea, psoriasis, eczema and seborrheic dermatitis.

Galderma Canada, was established in 1989 as an affiliate of Galderma, a global pharmaceutical company. Today, with a staff of 120+, we service approximately 5,000 healthcare professionals with a special focus on dermatology. Our Canadian Headquarters are located in Thornhill, Ontario. Galderma is wholly owned by Nestle's.

10 major brands; Benzac, Cetaphil, Clobex, Differin XP, Metro, Silkis, Apprilon, Onreltea, Metvix and Tactuo

The Skin – Our Passion for Dermatology
Galderma is built on the concept that dermatology holds a unique position in the improvement of human health and that deserves our undivided dedication. The skin is an organ unlike others. It is our interface with the world. Where Galderma stands out is in the passion that our employees, since the very early days, have developed for dermatology and skin health. Skin protects, touches, warms, feels, sweats and blushes. All of this is compromised when the skin is sick. Our work is directed to assure and recover the health of the skin.

As a leader, Galderma actively supports scientific, medical and educational initiatives focused on improving patient care and advancing the field of dermatology. In addition, the Company donates products to impact the lives of dermatology patients around the world who would not otherwise have access to innovative medicines.